KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Other financing activities: 2009-2025

Historic Other financing activities for Charles River Laboratories International (CRL) over the last 15 years, with Sep 2025 value amounting to -$6.2 million.

  • Charles River Laboratories International's Other financing activities rose 53.74% to -$6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.7 million, marking a year-over-year increase of 1.13%. This contributed to the annual value of -$31.4 million for FY2024, which is 658.55% down from last year.
  • Per Charles River Laboratories International's latest filing, its Other financing activities stood at -$6.2 million for Q3 2025, which was up 3.55% from -$6.5 million recorded in Q2 2025.
  • Charles River Laboratories International's Other financing activities' 5-year high stood at $28.7 million during Q1 2021, with a 5-year trough of -$15.5 million in Q2 2022.
  • Its 3-year average for Other financing activities is -$6.9 million, with a median of -$6.2 million in 2025.
  • Per our database at Business Quant, Charles River Laboratories International's Other financing activities spiked by 79,150.00% in 2021 and then slumped by 85,750.00% in 2022.
  • Quarterly analysis of 5 years shows Charles River Laboratories International's Other financing activities stood at $2,000 in 2021, then slumped by 85,750.00% to -$1.7 million in 2022, then tumbled by 136.50% to -$4.1 million in 2023, then tumbled by 224.87% to -$4.5 million in 2024, then spiked by 53.74% to -$6.2 million in 2025.
  • Its last three reported values are -$6.2 million in Q3 2025, -$6.5 million for Q2 2025, and -$4.5 million during Q4 2024.